Elanco Animal Health (ELAN) Return on Capital Employed Growth (3y) (2021 - 2026)
Elanco Animal Health (ELAN) Return on Capital Employed Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.60 Bn | 87.73 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.81 Bn | 32.07 Bn | 1.97 Bn | 1,301.00 |
| 3 | Zoetis | 32.47 Bn | 30.53 Bn | 1.62 Bn | 331.00 |
| 4 | Takeda Pharmaceutical | 27.55 Bn | 23.49 Bn | 4.39 Bn | -667.00 |
| 5 | United Therapeutics | 23.10 Bn | 20.95 Bn | 648.10 Mn | 480.00 |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.31 Bn | 18.50 Bn | 1.16 Bn | -254.00 |
| 8 | Neurocrine Biosciences | 17.77 Bn | 16.46 Bn | 800.70 Mn | 1,342.00 |
| 9 | Elanco Animal Health | 12.61 Bn | 12.18 Bn | 785.00 Mn | 1,902.00 |
| 10 | Vireo Growth | 10.52 Bn | 10.37 Bn | 59.30 Mn | -96.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,902.00 |
| Dec 31, 2025 | 1,939.00 |
| Sep 30, 2025 | 1,566.00 |
| Jun 30, 2025 | 1,486.00 |
| Mar 31, 2025 | 982.00 |
| Dec 31, 2024 | 513.00 |
| Sep 30, 2024 | 628.00 |
| Jun 30, 2024 | -590.00 |
| Mar 31, 2024 | -813.00 |
| Dec 31, 2023 | -862.00 |
| Sep 30, 2023 | -613.00 |
| Jun 30, 2023 | 395.00 |
| Mar 31, 2023 | 349.00 |
| Dec 31, 2022 | 253.00 |
| Sep 30, 2022 | 195.00 |
| Jun 30, 2022 | 126.00 |
| Mar 31, 2022 | 160.00 |
| Dec 31, 2021 | -16.00 |